abrdn Life Sciences Investors (NYSE: HQL) Stock Information | RedChip

abrdn Life Sciences Investors (NYSE: HQL)


$13.4500
+0.1700 ( +0.07% ) 98.0K

abrdn Life Sciences Investors operates as a non-diversified closed-end management investment company. Its investment objective is to seek long-term capital appreciation by investing primarily in securities of Life Sciences companies. It investsĀ in securities of public and private companies that are believed by the Fund's Investment Adviser, abrdn Inc to have significant potential for above-average growth.

Market Data


Open


$13.4500

Previous close


$13.2800

Volume


98.0K

Market cap


$378.13M

Day range


$13.3150 - $13.6690

52 week range


$12.7600 - $15.8999

SEC Filings


Form Type Description Pages Date
3 Insider transactions 2 Dec 20, 2024
3 Insider transactions 2 Dec 20, 2024
n-cen Other 5 Dec 16, 2024
n-csr Other 17 Dec 09, 2024
nport-p Other 1 Nov 27, 2024
n-px Other 2 Sep 03, 2024
nport-p Other 2 Aug 28, 2024
4 Insider transactions 1 Aug 27, 2024
4 Insider transactions 1 Jul 18, 2024
4 Insider transactions 1 Jun 27, 2024

Latest News